Education
About Us
Working with TipRanks
Follow Us
Sigyn Therapeutics (SIGY)
OTHER OTC:SIGY
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -8.86K | $ -10.45K | - | $ -11.30K |
| Operating Income | $ -2.52M | $ -2.46M | $ -2.15M | $ -2.01M | $ -916.43K |
| EBITDA | $ -2.52M | $ -2.45M | $ -2.14M | $ -2.53M | $ -905.13K |
| Net Income | $ -3.34M | $ -4.15M | $ -3.71M | $ -3.40M | $ -1.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 12.14K | $ 11.69K | $ 8.36K | $ 340.96K | $ 84.40K |
| Total Assets | $ 213.72K | $ 321.81K | $ 332.88K | $ 710.26K | $ 694.08K |
| Total Debt | $ 2.19M | $ 2.40M | $ 1.88M | $ 980.01K | $ 518.67K |
| Net Debt | $ 2.18M | $ 2.39M | $ 1.87M | $ 639.05K | $ 434.27K |
| Total Liabilities | $ 4.67M | $ 3.73M | $ 2.24M | $ 974.84K | $ 594.90K |
| Stockholders' Equity | $ -4.46M | $ -3.41M | $ -1.90M | $ -264.58K | $ 99.18K |
| Cash Flow | |||||
| Free Cash Flow | $ -872.44K | $ -1.38M | $ -1.83M | $ -1.80M | $ -840.61K |
| Operating Cash Flow | $ -872.44K | $ -1.38M | $ -1.83M | $ -1.77M | $ -829.81K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -860.00 | $ -29.26K | $ -10.80K |
| Financing Cash Flow | $ 872.89K | $ 1.39M | $ 1.50M | $ 2.06M | $ 925.01K |
Sigyn Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.